Forefront Wealth Management Inc. Acquires New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Forefront Wealth Management Inc. acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 4,595 shares of the healthcare conglomerate’s stock, valued at approximately $2,324,000. UnitedHealth Group comprises about 2.1% of Forefront Wealth Management Inc.’s investment portfolio, making the stock its 17th biggest position.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Plancorp LLC increased its holdings in UnitedHealth Group by 15.4% in the 4th quarter. Plancorp LLC now owns 12,805 shares of the healthcare conglomerate’s stock worth $6,478,000 after buying an additional 1,711 shares during the period. Runnymede Capital Advisors Inc. acquired a new position in UnitedHealth Group in the 4th quarter worth approximately $70,000. Cyrus J. Lawrence LLC increased its holdings in UnitedHealth Group by 5.2% in the 4th quarter. Cyrus J. Lawrence LLC now owns 611 shares of the healthcare conglomerate’s stock worth $309,000 after buying an additional 30 shares during the period. Mizuho Securities USA LLC increased its holdings in UnitedHealth Group by 45.7% in the 4th quarter. Mizuho Securities USA LLC now owns 87,222 shares of the healthcare conglomerate’s stock worth $44,122,000 after buying an additional 27,343 shares during the period. Finally, ZEGA Investments LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $5,358,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.3 %

NYSE UNH opened at $517.72 on Friday. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business’s fifty day simple moving average is $510.19 and its 200-day simple moving average is $547.47. The firm has a market cap of $473.57 billion, a PE ratio of 33.40, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the firm earned $5.83 EPS. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on UNH shares. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, Barclays decreased their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average target price of $629.32.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.